Other
Labs
Labs is an intervention with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
2
40%
Ph phase_2
1
20%
Ph not_applicable
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(1)
Detailed Status
Completed1
Terminated1
Withdrawn1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
N/A1 (25.0%)
Trials by Status
completed120%
terminated120%
withdrawn120%
recruiting120%
unknown120%
Recent Activity
1 active trials
Showing 5 of 5
terminatedphase_1
Next Generation Personalized Neuroblastoma Therapy
NCT02780128
recruitingphase_2
Bioenergetic Effect of Pioglitazone in CLD-PH
NCT06336798
unknown
Knowledge About Covid-19 Infection in Pregnant Women
NCT04423692
completedphase_1
A Randomized Multi-centre Study to Assess the Safety and Manageability of a Laparoscopic Adhesion Barrier in Women Undergoing Gynecologic Laparoscopic Surgery Followed by Second Look Laparoscopy
NCT02260115
withdrawnnot_applicable
Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass
NCT02288351
Clinical Trials (5)
Showing 5 of 5 trials
NCT02780128Phase 1
Next Generation Personalized Neuroblastoma Therapy
NCT06336798Phase 2
Bioenergetic Effect of Pioglitazone in CLD-PH
NCT04423692
Knowledge About Covid-19 Infection in Pregnant Women
NCT02260115Phase 1
A Randomized Multi-centre Study to Assess the Safety and Manageability of a Laparoscopic Adhesion Barrier in Women Undergoing Gynecologic Laparoscopic Surgery Followed by Second Look Laparoscopy
NCT02288351Not Applicable
Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5